Specific Tumor Component Spectrum as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer

被引：0
|
作者：
Xu, S. [1 ]
Cerussi, A. E. [1 ]
Tromberg, B. [1 ]
Gratton, E. [1 ]
机构：
[1] Univ Calif Irvine, Irvine, CA USA
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P5-01-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P5-01-12
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prediction of neoadjuvant chemotherapy response in breast cancer
    Izquierdo, M.
    Rodriguez, I.
    Tresserra, F.
    Baulies, S.
    Ara, C.
    Fabregas, R.
    BREAST, 2017, 32 : S79 - S79
  • [32] PREDICTION OF NEOADJUVANT CHEMOTHERAPY RESPONSE IN BREAST CANCER
    Myllys, Maiju
    EXCLI JOURNAL, 2021, 20 : 625 - 627
  • [33] Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
    Goorts, Briete
    van Nijnatten, Thiemo J. A.
    de Munck, Linda
    Moossdorff, Martine
    Heuts, Esther M.
    de Boer, Maaike
    Lobbes, Marc B. I.
    Smidt, Marjolein L.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (01) : 83 - 91
  • [34] Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
    Briete Goorts
    Thiemo J. A. van Nijnatten
    Linda de Munck
    Martine Moossdorff
    Esther M. Heuts
    Maaike de Boer
    Marc B. I. Lobbes
    Marjolein L. Smidt
    Breast Cancer Research and Treatment, 2017, 163 : 83 - 91
  • [35] Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer (vol 28, pg 105, 2010)
    Denkert
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (04) : 708 - 708
  • [36] The association of circulating tumor cells with tumor response in breast cancer patients undergoing neoadjuvant chemotherapy
    Raphael, Jacques
    Mohamadi, Reza
    Kiss, Alex
    Trudeau, Maureen
    Verma, Sunil
    Allan, Alison
    Kelley, Shana
    Helou, Joelle
    Lu, Fang-I
    Zhu, Siqi
    Pritchard, Kathleen I.
    CANCER RESEARCH, 2020, 80 (04)
  • [37] Characterization of Tumor Heterogeneity as a Predictor of Response to Neoadjuvant Chemotherapy in Locally-Advanced Rectal Cancer
    Greenbaum, A.
    Martin, D.
    Bocklage, T.
    Lee, J.
    Ness, S.
    Rajput, A.
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 : S105 - S106
  • [38] Topoisomerase 2 alpha as a predictor of response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer
    Shehata, M.
    Al-Attar, A.
    Reis-Filho, J.
    Ellis, I.
    Mukherjee, A.
    Chan, S.
    BREAST CANCER RESEARCH, 2010, 12 : S14 - S15
  • [39] The role of the angiogenic marker, endoglin, as a predictor of response to neoadjuvant chemotherapy in primary breast cancer.
    Beresford, MJ
    Ah-See, M
    Daley, F
    Richman, P
    Harris, A
    Makris, A
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S59 - S59
  • [40] Topoisomerase 2 alpha as a predictor of response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer
    M Shehata
    A Al-Attar
    J Reis-Filho
    I Ellis
    A Mukherjee
    S Chan
    Breast Cancer Research, 12
12345